Azerbaijan vs Estonia: Previously treated cases tested for RR-/MDR-TB
Azerbaijan
94.0%
in 2024
Estonia
94.0%
in 2024
Azerbaijan rank
72nd
Estonia rank
72nd
Previously treated cases tested for RR-/MDR-TB over time
- Azerbaijan
- Estonia
How they compare
Azerbaijan currently reports 94.0% against 94.0% in Estonia, a difference of 0.0%.
The two have swapped places 6 times across 18 shared years of data; in 2005 it was Estonia ahead.
Azerbaijan ranks 72nd and Estonia ranks 72nd of 180 countries.
Across the 3 decades both report, Azerbaijan averaged higher in 1 and Estonia in 2.
Head to head by decade
| Decade | Azerbaijan | Estonia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.6% | 80.7% | 70.0% | Estonia |
| 2010s | 66.6% | 81.6% | 15.0% | Estonia |
| 2020s | 98.4% | 90.6% | 7.8% | Azerbaijan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Azerbaijan or Estonia?
- Azerbaijan, at 94.0% against 94.0% in Estonia as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Azerbaijan and Estonia?
- 0.0%, with Azerbaijan ahead.
- How many years of comparable data are there for Azerbaijan and Estonia?
- 18 years are reported by both, from 2005 to 2024.
- How do Azerbaijan and Estonia rank globally for previously treated cases tested for rr-/mdr-tb?
- Azerbaijan ranks 72nd and Estonia ranks 72nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.